IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Terns Pharmaceuticals Inc (TERN)

CUSIP: 880881107 | NYSE | Healthcare · Biotechnology | Mid Cap | 512 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Mizuho Securities USA LLC11,083
0.0% of portfolio›$584.3K
IFP Advisors, Inc1,424
0.0% of portfolio›$75.4K
StyleTurnoverLocationFiled
Mizuho Securities USA LLC
11,083$584.3K0.0%GrowthMediumNew York, NY2026-07-28
IFP Advisors, Inc
1,424$75.4K0.0%GrowthLowTampa, FL2026-07-20